WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13-14 May 2009

Morag Ferguson; Jinho Shin; Ivana Knezevic; Philip Minor; Alan Barrett; WHO Working Group

doi:10.1016/j.vaccine.2010.10.070

WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13-14 May 2009

Vaccine. 2010 Dec 6;28(52):8236-45. doi: 10.1016/j.vaccine.2010.10.070. Epub 2010 Nov 4.

Authors

Morag Ferguson¹, Jinho Shin, Ivana Knezevic, Philip Minor, Alan Barrett; WHO Working Group

Affiliation

¹ National Institute of Biological Standards and Control, Potters Bar, England, UK.

Abstract

In May 2009, WHO convened a meeting of Working Group on Technical Specifications for Manufacturing and Evaluating Yellow Fever (YF) Vaccines, Geneva, Switzerland to initiate revision of the WHO Recommendations (formerly, Requirements) for YF vaccine published in WHO Technical Report Series number 872 (1998). The Working Group, consisting of experts from academia, industry, national regulatory authorities and national control laboratories, reviewed the latest issues of safety, efficacy and quality of YF vaccines and agreed that (i) the revision should focus on live attenuated YF vaccine virus 17D lineage; and that (ii) nonclinical and clinical guidelines for new vaccines prepared from 17D lineage be developed.

Publication types

Congress

MeSH terms

Guidelines as Topic
Humans
Switzerland
Vaccines, Attenuated / adverse effects
Vaccines, Attenuated / immunology
World Health Organization
Yellow Fever / immunology*
Yellow Fever / prevention & control*
Yellow Fever Vaccine / adverse effects*
Yellow Fever Vaccine / immunology*

Substances

Vaccines, Attenuated
Yellow Fever Vaccine